OptiBiotix Health PLC (OPTI)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

6.50p

Buy

7.00p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 15:14 GMT

Prices minimum 15 mins delay

Prices in GBX

OptiBiotix Health PLC is a life sciences company. The company through its subsidiaries is engaged in the research and development of microbiome modulators.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Mr. Richard Colin Neil Davidson CBE

CEO

Mr. Stephen Patrick O'Hara

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

10

Head office

Innovation Centre, Innovation Way

York

United Kingdom

YO10 5DG

+44 1904435100

info@optibiotix.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Richard Colin Neil Davidson CBE Non-Executive Director, Chairman	-
Mr. Michael Sean Christie Non-Executive Director	-
Dr. Sofia Kolyda Executive Director, Research and Development	-
Mr. David Jonathan Blain Executive Director, Finance Director and Company Secretary	-
Mr. Stephen Patrick O'Hara Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
No data

Director dealings

Date chevron-l-regular chevron-r-regular	Action
01 Oct 2025	Purchase
23 Sep 2025	Purchase
23 Sep 2025	Purchase
22 Sep 2025	Purchase
22 Sep 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.